Illumina, Inc. (ticker: ILMN, exchange: NASDAQ Global Select Market (.O))
News Release -
Illumina to Webcast Presentation at JP Morgan Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Jan. 4, 2006--Illumina, Inc.
(NASDAQ:ILMN) announced today that Jay Flatley, President and CEO,
will present an overview of the Company's commercial and product
development activity at the upcoming JP Morgan Healthcare Conference
in San Francisco, CA.
Mr. Flatley's presentation will be webcast live beginning on or
about 8:00 a.m. Pacific Time (PT) on Thursday, January 12, 2006. The
webcast presentation may be accessed at
http://equityconferences.jpmorgan.com/where it will be archived for
30 days following the presentation.
Illumina (www.illumina.com) is developing next-generation tools
that permit large-scale analysis of genetic variation and function.
The Company's proprietary BeadArray(TM) technology -- now used in
leading genome centers around the world -- provides the throughput,
cost effectiveness and flexibility to enable researchers in the life
sciences and pharmaceutical industries to perform the billions of
tests necessary to extract medically valuable information from
advances in genomics and proteomics. This information will help pave
the way to personalized medicine by correlating genetic variation and
gene function with particular disease states, enhancing drug
discovery, allowing diseases to be detected earlier and more
specifically, and permitting better choices of drugs for individual
CONTACT: Illumina, Inc.
Jay Flatley, 858-202-4501
William Craumer, 858-202-4667
SOURCE: Illumina, Inc.